US 7410781
IL-4/IL-13 specific polypeptides and therapeutic uses thereof
granted A61PA61P1/00A61P1/16
Quick answer
US patent 7410781 (IL-4/IL-13 specific polypeptides and therapeutic uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P1/00, A61P1/16, A61P11/00, A61P11/16